You just read:

RegeneRx Collaborators Receive Notice of 'Intent to Grant' EU Patent for the Treatment of Peripheral Neuropathy

News provided by

RegeneRx Biopharmaceuticals, Inc.

Aug 14, 2017, 09:21 ET